384 results on '"Walldius, Göran"'
Search Results
2. Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
3. The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age
4. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort
5. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
6. Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study
7. Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort
8. Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study
9. Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers
10. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
11. Lipids, Apolipoproteins, and the Risk of Parkinson Disease: A Prospective Cohort Study and a Mendelian Randomization Analysis
12. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
13. Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
14. Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population
15. Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers
16. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort
17. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
18. Iron metabolism and risk of cancer in the Swedish AMORIS study
19. Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers.
20. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
21. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
22. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
23. Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort
24. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study
25. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients
26. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis
27. The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism
28. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
29. Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort.
30. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study
31. Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
32. Prostate cancer risk in the Swedish AMORIS study: The interplay among triglycerides, total cholesterol, and glucose
33. Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
34. A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group
35. Association of Serum Immunoglobulin Levels with Solid Cancer: A Systematic Review and Meta-analysis
36. Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
37. Apolipoprotein B (apoB) more closely related to subclinical atherosclerosis than non-HDL cholesterol and LDL cholesterol
38. Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow‐up
39. Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
40. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
41. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
42. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
43. Effects of nicotinic acid treatment on glyceride formation and lipolysis in adipose tissue of hyperlipidemic patients
44. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy
45. Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females
46. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
47. SAT-297-Prediction of incident severe liver disease in the general population using non-invasive scoring systems
48. Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort
49. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
50. Antioxidants and atherosclerosis progression: unresolved questions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.